Today, the authorities of Piedmont, Italy, stated about temporarily stop the use of the batch of AstraZeneca vaccine after the death of a teacher from Biella who was vaccinated by this drug as Reuters reported.
AstraZeneca vaccine will not be used until the batch is identified and isolated.
The region expects the results of the checks whether or not there is a tie between the death and the vaccination, as well as the decision of the Italian Medicines Agency (AIFA) and the regional health commission on this issue.
Head of the regional health services Luigi Genesio Icardi stated that as of today, there were no critical issues with the administration of vaccines.
Literally, in 30 minutes after the decision to stop the vaccination by AstraZeneca, AIFA President Giorgio Palu stated that there is no tie between the death of a teacher in Piedmont and the vaccination as Orizzontescuola.it reported.
“As of today, it is true for AstraZeneca, there is no correlation or cause-effect relationship between the vaccination and lethal cases that occurred,” Palu stated.
He believes "it is necessary to be very careful" before making such steps.
As we reported, the European Medicines Agency (EMA) considers the reports on side effects of the AstraZeneca vaccine. The issue is about information from a few EU countries on the blood clots of some vaccinated people.
Due to the blood clots, some countries stopped the use of the AstraZeneca vaccine; particularly, Denmark, Austria, Estonia, Lithuania, Luxembourg, Latvia and Cyprus. Norway is not an EU member but it also stopped the use of AstraZeneca. Later, Bulgaria, Thailand and Romania joined this list; while a woman died after AstraZeneca shot in Croatia.
However, the World Health Organization sees no reason to stop using AstraZeneca’s Covid-19 vaccine. It is underlined that it was an “excellent vaccine” and that no causal relationship had been established between it and the health problems reported.
Later, AstraZeneca Company stated its vaccine does not lead to blood clotting ability issues.